9.60

6.64% 0.56

Lexaria Bioscience Corp (LEXX)

Overview News Price History Financials Discussions Forecast Stock Split

Lexaria Bioscience Corp stock is traded at $9.60, with a volume of 20,185. It is up +6.64% in the last 24 hours and up +1,415% over the past month. Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Previous Close:

$9.04

Open:

$9.31

24h Volume:

20,185

Relative Volume:

0.23

Market Cap:

$15.17M

Revenue:

$368.00K

Net Income/Loss:

$-9.54M

P/E Ratio:

-20.05

EPS:

-0.4788

Net Cash Flow:

$-9.47M

1W Performance:

+75.59%

1M Performance:

+1,415%

6M Performance:

+1,384%

1Y Performance:

+1,076%

1-Day Range:

$8.74

$9.86

1-Week Range:

$5.50

$9.86

52-Week Range:

$0.35

$9.86

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name

Lexaria Bioscience Corp

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

250-765-6424

Address

100 - 740 MCCURDY ROAD, KELOWNA

Employee

Twitter

Next Earnings Date

2026-07-13

Latest SEC Filings

LEXX's Discussions on Twitter

Compare LEXX vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LEXX Lexaria Bioscience Corp	9.18	14.94M	368.00K	-9.54M	-9.47M	-0.4788
VRTX Vertex Pharmaceuticals Inc	515.67	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	805.59	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	993.07	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.47	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.63	39.31B	5.76B	514.49M	1.10B	4.4813

Lexaria Bioscience Corp Stock (LEXX) Latest News

01:25 AM

Lexaria Bioscience regains Nasdaq compliance, stock to remain listed By Investing.com - Investing.com India

01:25 AM

01:09 AM

Lexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing - TipRanks

01:09 AM

12:57 PM

Lexaria Bioscience regains Nasdaq compliance, stock to remain listed - Investing.com

12:57 PM

12:50 PM

Form 8K LEXARIA BIOSCIENCE CORP. For: 17 August By Investing.com - Investing.com Canada

12:50 PM

12:43 PM

Lexaria Bioscience regains Nasdaq bid-price compliance, listing continued - TradingView

12:43 PM

12:38 PM

Delisting risk eases as Lexaria (NASDAQ: LEXX) regains bid-price compliance - Stock Titan

12:38 PM

04:20 AM

LEXX Looks 64.3% Overvalued on GF Value™ - GuruFocus

04:20 AM

Aug 13, 2026

Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Know - Benzinga

Aug 13, 2026

Lexaria Signs PegBio Deal to Test DehydraTECH With GLP-1 Diabetes Drug - TipRanks

Aug 13, 2026

Lexaria enters partnership with PegBio for GLP-1 drug delivery - Investing.com

Aug 13, 2026

Lexaria Enters a Material Transfer Agreement With PegBio - Investing News Network

Aug 13, 2026

Lexaria enters partnership with PegBio for GLP-1 drug delivery By Investing.com - Investing.com India

Aug 13, 2026